TIL Gean Therapy

tumor-infiltrating lymphocyte therapy · Essen Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TIL Gean Therapy, covering 2024-11-12 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer [Phase 1, Phase 2]

See pricing